Adherence of Hispanic / Latina Breast Cancer - Patients to Adjuvant Aromatase Inhibitors

Completed

Conditions studied: Breast Cancer

In brief

This is an observational trial designed to assess prospectively the adherence rate to AIs among women with invasive breast cancer (stages I-III) currently receiving AI adjuvant therapy after standard local and systemic therapy. We will study adherence by administrating the 8-item Morisky Medication Adherence Scale (MMAS - 8).

Key facts

Study ID

NCT03144037

Run by

Texas Tech University Health Sciences Center, El Paso

People needed

152

Starts

2017-04-26

Expected to finish

2021-03-19

Last updated by the study team

2021-03-29

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Post - menopausal women with histologically confirmed hormonal positive (ER and/or PR) invasive breast cancer stages I - III with no evidence of metastatic disease (M0).
• Patient must have completed local treatment (surgery /radiation) and recovered from all side effects of chemotherapy and surgery.
• Patient must be on one of AI (steroidal or non-steroidal).
• Patient must be able to complete a demographic and the MMAS - 8 questionnaires in English or Spanish

You may not qualify if…

• < 18 years old

Where it is running

• Texas Tech University HSC El Paso — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.